Stay updated with breaking news from Richardh Scheller. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DICE Therapeutics, Inc. (NASDAQ:DICE – Get Free Report)’s stock price hit a new 52-week high during mid-day trading on Wednesday . The company traded as high as $47.25 and last traded at $47.19, with a volume of 251519 shares trading hands. The stock had previously closed at $47.21. Analyst Ratings Changes A number of research […]
DICE Therapeutics, Inc. (NASDAQ:DICE – Free Report) – Research analysts at Cantor Fitzgerald issued their FY2024 earnings per share (EPS) estimates for DICE Therapeutics in a research report issued to clients and investors on Tuesday, July 11th. Cantor Fitzgerald analyst P. Agrawal anticipates that the company will earn ($2.81) per share for the year. Cantor […]
Guggenheim cut shares of DICE Therapeutics (NASDAQ:DICE – Get Rating) from a buy rating to a neutral rating in a report published on Wednesday morning, The Fly reports. DICE has been the topic of several other reports. Cowen assumed coverage on shares of DICE Therapeutics in a research note on Wednesday, March 1st. They set […]
DICE Therapeutics (NASDAQ:DICE – Get Rating) had its price objective boosted by Wells Fargo & Company from $38.00 to $48.00 in a research note issued to investors on Tuesday morning, The Fly reports. Several other research analysts have also commented on DICE. TD Cowen started coverage on DICE Therapeutics in a report on Wednesday, March […]
DICE Therapeutics (NASDAQ:DICE – Get Rating) was downgraded by equities researchers at Stifel Nicolaus from a “buy” rating to a “hold” rating in a research report issued on Tuesday, The Fly reports. DICE has been the subject of a number of other reports. Cowen started coverage on shares of DICE Therapeutics in a research report […]